Concepedia

Maxime Soumeillant

MS

16

Publications

538

Citations

14

H-Index

1995

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (United Kingdom)

Bristol-Myers Squibb (Germany)

Maxime Soumeillant is an author at Bristol-Myers Squibb (United States) specializing in chemistry, organic chemistry, and engineering.

Top concepts

ChemistryOrganic ChemistryEngineeringPharmacologyNatural SciencesMedicineBiochemistryMedicinal ChemistryDrug DiscoveryChemical Engineering

Publications per year

1995–2022

16

Publications

16

Mild and General Methods for the Palladium-Catalyzed Cyanation of Aryl and Heteroaryl Chlorides

Adam F. Littke, Maxime Soumeillant, Robert F. Kaltenbach et al. · Organic Letters · 2007 · 140 citations

Chemical Engineering, Cross-coupling Reaction, Aryl Chlorides +10

Rhodium‐Catalyzed Cyclopropanation of Alkenes with Dimethyl Diazomalonate

Francisco González‐Bobes, Michaël D. B. Fenster, Susanne Kiau et al. · Advanced Synthesis & Catalysis · 2008 · 79 citations · Full text

Chemical Engineering, Cross-coupling Reaction, Engineering +12

Synthesis of the 6-Azaindole Containing HIV-1 Attachment Inhibitor Pro-Drug, BMS-663068

Ke Chen, Christina A. Risatti, Michael Bultman et al. · The Journal of Organic Chemistry · 2014 · 41 citations

Organic Chemistry, Chemistry, Heterocycle Chemistry +19

Development of a Commercial Process for Deucravacitinib, a Deuterated API for TYK2 Inhibition

Daniel S. Treitler, Maxime Soumeillant, Eric M. Simmons et al. · Organic Process Research & Development · 2022 · 34 citations

Access Deucravacitinib, Pharmacotherapy, Antimicrobial Chemotherapy +21

Kilogram Synthesis of a Selective Serotonin Reuptake Inhibitor

Robert Anthes, Osagie Bello, Serge Benoit et al. · Organic Process Research & Development · 2008 · 33 citations

Combinatorial Chemistry, Active Pharmaceutical Ingredient, Process Development +17

Rows per page

1–5 of 16